| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2019 | Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis. | Gao, X; Yang, HI ; Trinh, H; Jeong, D; Li, J; Zhang, J; Le, A; Hoang, J; Nguyen, P; Henry, L; Nguyen, MH | European Journal of Gastroenterology & Hepatology Volume Publish Ahead of Print | | | |
| 2021 | Cultivation of Caenorhabditis elegans on new cheap monoxenic media without peptone | Le, TS; Nguyen, TTH; Huong, BTM; Nguyen, HG; Ha, BH; Nguyen, VS; Nguyen, MH; Nguyen, H-H; Wang, J | JOURNAL OF NEMATOLOGY 53, e2021-36 | | | |
| 2021 | Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B | Le, AK; Yang, HI ; Yeh, ML; Jin, M; Trinh, HN; Henry, L; Liu, A; Zhang, JQ; Li, J; Wong, C; Wong, C; Cheung, R; Yu, ML; Nguyen, MH | JOURNAL OF INFECTIOUS DISEASES 223(1), 139-146 | | | |
| 2019 | Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. | Huang, CF; Iio, E; Jun, DW; Ogawa, E; Toyoda, H; Hsu, YC; Haga, H; Iwane, S; Enomoto, M; Lee, DH; Wong, G; Liu, CH; Tada, T; Chuang, WL; Cheung, R; Hayashi, J; Tseng, CH; Yasuda, S; Tran, S; Kam, L; Henry, L; Jeong, JY; Nomura, H; Park, SH; Nakamuta, M; Huang, JF; Tai, CM; Lo, GH; Lee, MH; Yang, HI ; Kao, JH; Tamori, A; Eguchi, Y; Ueno, Y; Furusyo, N; Tanaka, Y; Yu, ML; Nguyen, MH | Hepatology international 13, 587-598 | | | |
| 2019 | Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. | Yeo, YH; Ho, HJ; Yang, HI ; Tseng, TC; Hosaka, T; Trinh, HN; Kwak, MS; Park, YM; Fung, JYY; Buti, M; Rodriguez, M; Treeprasertsuk, S; Preda, CM; Ungtrakul, T; Charatcharoenwitthaya, P; Li, X; Li, J; Zhang, J; Le, MH; Wei, B; Zou, B; Le, A; Jeong, D; Chien, N; Kam, L; Lee, CC; Riveiro-Barciela, M; Istratescu, D; Sriprayoon, T; Chong, Y; Tanwandee, T; Kobayashi, M; Suzuki, F; Yuen, MF; Lee, HS; Kao, JH; Lok, AS; Wu, CY; Nguyen, MH | Gastroenterology 156(3), 635-646.e9 | | | |
| 2021 | Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study | Wang, Z; Budhu, AS; Shen, Y; Wong, LL; Hernandez, BY; Tiirikainen, M; Ma, X; Irwin, ML; Lu, L; Zhao, H; Lim, JK; Taddei, T; Mishra, L; Pawlish, K; Stroup, A; Brown, R; Nguyen, MH; Koshiol, J; Hernandez, MO; Forgues, M; Yang, HI ; Lee, MH; Huang, YH; Iwasaki, M; Goto, A; Suzuki, S; Matsuda, K; Tanikawa, C; Kamatani, Y; Mann, D; Guarnera, M; Shetty, K; Thomas, CE; Yuan, JM; Khor, CC; Koh, WP; Risch, H; Wang, XW; Yu, H | JGH open 5(12), 1363-1372 | | | |
| 2019 | HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. | Ogawa, E; Toyoda, H; Iio, E; Jun, DW; Huang, CF; Enomoto, M; Hsu, YC; Haga, H; Iwane, S; Wong, G; Lee, DH; Tada, T; Liu, CH; Chuang, WL; Hayashi, J; Cheung, R; Yasuda, S; Tseng, CH; Takahashi, H; Tran, S; Yeo, YH; Henry, L; Barnett, SD; Nomura, H; Nakamuta, M; Dai, CY; Huang, JF; Yang, HI ; Lee, MH; Jung Jun, M; Kao, JH; Eguchi, Y; Ueno, Y; Tamori, A; Furusyo, N; Yu, ML; Tanaka, Y; Nguyen, MH; Ahn, SB; Azuma, K; Dohmen, K; Yoon Jeong, J; Jung, JH; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Ooho, A; Park, SH; Satoh, T; Shimoda, S; Song, DS; Takahashi, K; Yeh, ML; Yoon, EL | Clinical Infectious Diseases, ciz1160 | | | |
| 2017 | Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 186-187 | | | |
| 2017 | Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 182-183 | | | |
| 2016 | Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. | Hoang, JK; Yang, HI ; Le, A; Nguyen, NH; Lin, D; Vu, VD; Chaung, K; Nguyen, V; Trinh, HN; Li, J; Zhang, JQ; Chen, CJ ; Nguyen, MH | Medicine 95(31), e4433 | | | |
| 2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2019 | Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir—A Propensity Score–Matched Study | Nguyen, MH; Yang, HI ; Le, A; Henry, L; Nguyen, N; Lee, MH; Zhang, J; Wong, C; Wong, C; Trinh, H | The Journal of infectious diseases 219(1), 10-18 | | | |
| 2016 | Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients | Lin, D; Yang, HI; Nguyen, N; Hoang, J; Kim, Y; Vu, V; Le, A; Chaung, K; Nguyen, V; Trinh, H; Li, J; Zhang, J; Hsing, A; Chen, CJ ; Nguyen, MH | Alimentary pharmacology & therapeutics 44(8), 846-855 | | | |
| 2016 | Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. | Lin, D; Yang, HI; Nguyen, N; Hoang, J; Kim, Y; Vu, V; Le, A; Chaung, K; Nguyen, V; Trinh, H; Li, J; Zhang, J; Hsing, A; Chen, CJ; Nguyen, MH | Alimentary pharmacology & therapeutics 44(8), 846-855 | | | |
| 2022 | Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B | Hu, HH; Jeng, WJ; Pan, MH; Luo, WS; Chang, CL; Huang, YT ; Su, CY; Chiang, CT; Jen, CL; Chien, YC; Lu, SN; Wang, LY; Huang, LR; Lee, MH; Liu, J; Nguyen, MH; Chen, CJ ; Yang, HI | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 55(5), 558-567 | | | |
